Evidence map›Paper›PMID 24533103›Full record

ArticlePloS one2014

CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals.

Alejandra Pera, Carmen Campos, Alonso Corona, Beatriz Sanchez-Correa, Raquel Tarazona, Anis Larbi, Rafael Solana

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Functional Changes of T-Cell Subsets with Age and CMV Infection.International journal of molecular sciences · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Alejandra PeraDepartment of Immunology, Maimonides Institute for Biomedical Research (IMIBIC) - Reina Sofía University Hospital - University of Cordoba, Cordoba, Spain.
Carmen CamposDepartment of Immunology, Maimonides Institute for Biomedical Research (IMIBIC) - Reina Sofía University Hospital - University of Cordoba, Cordoba, Spain.
Alonso CoronaDepartment of Immunology, Maimonides Institute for Biomedical Research (IMIBIC) - Reina Sofía University Hospital - University of Cordoba, Cordoba, Spain.
Beatriz Sanchez-CorreaImmunology Unit, Department of Physiology, University of Extremadura, Cáceres, Spain.
Raquel TarazonaImmunology Unit, Department of Physiology, University of Extremadura, Cáceres, Spain.
Anis LarbiSingapore Immunology Network (SIgN), Biopolis, Agency for Science, Technology and Research, Singapore, Singapore.
Rafael SolanaDepartment of Immunology, Maimonides Institute for Biomedical Research (IMIBIC) - Reina Sofía University Hospital - University of Cordoba, Cordoba, Spain.
Instituto Maimónides de Investigación Biomédica de Córdoba · ESUniversidad de Extremadura · ESUniversity of Córdoba · ESAgency for Science, Technology and Research · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytomegalovirus (CMV) latent infection has a deleterious effect on the efficacy of influenza vaccination in the elderly, suggesting that CMV restricts immunological diversity impairing the immune system functionality in old age. Polyfunctional T cells produce multiple cytokines and higher amounts than mono-functional T cells. High number of polyfunctional T cells correlates with better prognosis during infection. Thus, the efficiency of T cell response associates with quality (polyfunctionality) rather than with quantity (percentage of T cells). We analyze the effect of CMV infection on CD8+ T cells polyfunctionality --degranulation (CD107a), IFN-gamma and TNF-alpha production--, from young CMV-seropositive and CMV-seronegative individuals and in middle age CMV-seropositive donors, in response to Staphylococcal Enterotoxin B (SEB). Our results show a higher percentage of polyfunctional CD8+ T cells in young CMV-seropositive individuals compared to CMV-seronegative. Also, we find an expansion of CD8+CD57+ T cells in CMV-seropositive individuals, which are more polyfunctional than CD8+CD57- cells. In middle age individuals there is a higher frequency of SEB-responding CD8+ T cells, mainly TNF-alpha or TNF-alpha/IFN-gamma producers, whereas the percentage of polyfunctional cells (IFN-gamma/TNF-alpha/CD107a) is similar to the percentages found in young CMV-seropositive. Therefore, whereas it has been shown that CMV latent infection can be detrimental for immune response in old individuals, our results indicate that CMV-seropositivity is associated to higher levels of polyfunctional CD8+ T cells in young and middle age donors. This increase in polyfunctionality, which can provide an immunological advantage in the response to other pathogens, is due to a CD8+CD57+ T cell expansion in CMV-seropositive individuals and it is independent of age. Conversely, age could contribute to the inflammation found in old individuals by increasing the percentage of cells producing pro-inflammatory cytokines. These findings highlight the necessity of further studies on the benefits/detrimental effects of CMV infection in the response to vaccination and other infections.

Indexed as

AdolescentAdultAge FactorsCD3 ComplexCD57 AntigensCD8-Positive T-LymphocytesCytomegalovirus InfectionsEnterotoxinsFemaleFlow CytometryGene Expression RegulationHumansInterferon-gammaLeukocytes, MononuclearLysosomal-Associated Membrane Protein 1MaleCD3 ComplexCD57 Antigensenterotoxin B, staphylococcalEnterotoxinsInterferon-gammaLysosomal-Associated Membrane Protein 1Tumor Necrosis Factor-alpha

Identifiers

PMID24533103
PMCPMC3922920
OpenAlexW2016769562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.